Feb.​ 16,​ 2018



Note from the editor


BioPharma Dive will not publish on Monday, Feb. 19, because the U.S. financial markets will close in observance of Presidents Day.

If you're looking to catch up on reading over the long weekend, check out BioPharma Dive's recent reports on Vivek Ramaswamy's continued faith in Roivant's model, or on pharma's growing interest in virtual reality marketing. Oh, and Bristol-Myers recently made a pretty big bet on Nektar Therapeutics' experimental cancer immunotherapy.

As always, feel free to reach out with any tips or questions. We'll be back in your inboxes Tuesday.


Ned Pagliarulo
Editor, BioPharma Dive

Top news

Read more news


Accelerating Life Science R&D with Digital Platforms
Life science CEOs are realizing a “digital transformation” is essential to financial success. Download this report featuring research from Gartner to learn about the future of Digital R&D.



What We're Reading


Suggest a story we should read

Upcoming Event


Dive Into a Topic